Jiang Wenkai, Li Xin, Xiang Caifei, Zhou Wence
The First Clinical Medical College, Lanzhou University, Lanzhou, China.
The Second Clinical Medical College, Lanzhou University, Lanzhou, China.
Front Oncol. 2022 Oct 17;12:1025805. doi: 10.3389/fonc.2022.1025805. eCollection 2022.
Pancreatic cancer is a digestive system malignancy and poses a high mortality worldwide. Traditionally, neutrophils have been thought to play a role in acute inflammation. In contrast, their importance during tumor diseases has been less well studied. Generally, neutrophils are recruited into the tumor microenvironment and exert inflammation and tumor-promoting effects. As an essential part of the tumor microenvironment, neutrophils play diverse roles in pancreatic cancer, such as angiogenesis, progression, metastasis and immunosuppression. Additionally, neutrophils can be a new potential therapeutic target in cancer. Inhibitors of cytokines, chemokines and neutrophil extracellular traps can exert antitumor effects. In this review, we describe the role of neutrophils in the development and progression of pancreatic cancer, discuss their potential as therapeutic targets, and aim to provide ideas for improving the prognosis of patients with this malignant tumor disease.
胰腺癌是一种消化系统恶性肿瘤,在全球范围内具有很高的死亡率。传统上,中性粒细胞被认为在急性炎症中发挥作用。相比之下,它们在肿瘤疾病中的重要性研究较少。一般来说,中性粒细胞被招募到肿瘤微环境中,并发挥炎症和促肿瘤作用。作为肿瘤微环境的重要组成部分,中性粒细胞在胰腺癌中发挥多种作用,如血管生成、进展、转移和免疫抑制。此外,中性粒细胞可能是癌症治疗的一个新的潜在靶点。细胞因子、趋化因子和中性粒细胞胞外陷阱的抑制剂可发挥抗肿瘤作用。在这篇综述中,我们描述了中性粒细胞在胰腺癌发生发展中的作用,讨论了它们作为治疗靶点的潜力,旨在为改善这种恶性肿瘤疾病患者的预后提供思路。